NAPIGEN, Inc. Secures U.S. Patent, Awarded USDA SBIR Grant
The patented claims of US11920140 are directed to methods for altering the genomes of mitochondria or plastids.
- The patented claims of US11920140 are directed to methods for altering the genomes of mitochondria or plastids.
- The mitochondria, also known as the powerhouses of cells, are critical components of plant, fungal, algal, and animal cells.
- It is the third SBIR grant the company has received since its founding in 2016.
- NAPIGEN, Inc. expects to complete a Series A financing this year to advance partnerships with agricultural companies to bring products to market.